These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29878008)

  • 1. Volatile organic compound signature from co-culture of lung epithelial cell line with Pseudomonas aeruginosa.
    Lawal O; Knobel H; Weda H; Bos LD; Nijsen TME; Goodacre R; Fowler SJ
    Analyst; 2018 Jul; 143(13):3148-3155. PubMed ID: 29878008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS.
    Lawal O; Muhamadali H; Ahmed WM; White IR; Nijsen TME; Goodacre R; Fowler SJ
    J Breath Res; 2018 Jan; 12(2):026002. PubMed ID: 28947683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.
    Filipiak W; Sponring A; Baur MM; Filipiak A; Ager C; Wiesenhofer H; Nagl M; Troppmair J; Amann A
    BMC Microbiol; 2012 Jun; 12():113. PubMed ID: 22716902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TD/GC-MS analysis of volatile markers emitted from mono- and co-cultures of
    Lawal O; Knobel H; Weda H; Nijsen TME; Goodacre R; Fowler SJ;
    Metabolomics; 2018; 14(5):66. PubMed ID: 29725275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa.
    Shestivska V; Spaněl P; Dryahina K; Sovová K; Smith D; Musílek M; Nemec A
    J Appl Microbiol; 2012 Sep; 113(3):701-13. PubMed ID: 22726261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono- and co-cultures based on volatile biomarker combinations.
    Neerincx AH; Geurts BP; Habets MFJ; Booij JA; van Loon J; Jansen JJ; Buydens LMC; van Ingen J; Mouton JW; Harren FJM; Wevers RA; Merkus PJFM; Cristescu SM; Kluijtmans LAJ
    J Breath Res; 2016 Jan; 10(1):016002. PubMed ID: 26824272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of chemically and biologically induced inflammation on the volatile metabolite production of lung epithelial cells by GC×GC-TOFMS.
    Zanella D; Henket M; Schleich F; Dejong T; Louis R; Focant JF; Stefanuto PH
    Analyst; 2020 Aug; 145(15):5148-5157. PubMed ID: 32633741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.
    Kamal F; Kumar S; Edwards MR; Veselkov K; Belluomo I; Kebadze T; Romano A; Trujillo-Torralbo MB; Shahridan Faiez T; Walton R; Ritchie AI; Wiseman DJ; Laponogov I; Donaldson G; Wedzicha JA; Johnston SL; Singanayagam A; Hanna GB
    Am J Respir Crit Care Med; 2021 Nov; 204(9):1075-1085. PubMed ID: 34319857
    [No Abstract]   [Full Text] [Related]  

  • 11. Modeling cellular metabolomic effects of oxidative stress impacts from hydrogen peroxide and cigarette smoke on human lung epithelial cells.
    Yamaguchi MS; McCartney MM; Falcon AK; Linderholm AL; Ebeler SE; Kenyon NJ; Harper RH; Schivo M; Davis CE
    J Breath Res; 2019 Jun; 13(3):036014. PubMed ID: 31063985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breath metabolome of mice infected with Pseudomonas aeruginosa.
    Purcaro G; Nasir M; Franchina FA; Rees CA; Aliyeva M; Daphtary N; Wargo MJ; Lundblad LKA; Hill JE
    Metabolomics; 2019 Jan; 15(1):10. PubMed ID: 30830447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.
    Schnabel R; Fijten R; Smolinska A; Dallinga J; Boumans ML; Stobberingh E; Boots A; Roekaerts P; Bergmans D; van Schooten FJ
    Sci Rep; 2015 Nov; 5():17179. PubMed ID: 26608483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
    Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
    J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of bacteria using volatile organic compounds.
    Karami N; Karimi A; Aliahmadi A; Mirzajan F; Rezadoost H; Ghassempour A; Fallah F
    Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):112-121. PubMed ID: 28364792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HS-GC-MS analysis of volatile organic compounds after hyperoxia-induced oxidative stress: a validation study.
    Lilien TA; Fenn DW; Brinkman P; Hagens LA; Smit MR; Heijnen NFL; van Woensel JBM; Bos LDJ; Bem RA;
    Intensive Care Med Exp; 2024 Feb; 12(1):14. PubMed ID: 38345723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile organic compounds in headspace characterize isolated bacterial strains independent of growth medium or antibiotic sensitivity.
    Hintzen KFH; Blanchet L; Smolinska A; Boumans ML; Stobberingh EE; Dallinga JW; Lubbers T; van Schooten FJ; Boots AW
    PLoS One; 2024; 19(1):e0297086. PubMed ID: 38277384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of H
    Liu Y; Li W; Duan Y
    J Breath Res; 2019 Apr; 13(3):036005. PubMed ID: 30925484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.